| Literature DB >> 30760263 |
Sonia Jain1, Rukhsana Chowdhury2, Mousumi Datta3, Goutam Chowdhury4, Asish Kumar Mukhopadhyay4.
Abstract
BACKGROUND: To analyze the molecular epidemiology and to compare between the major methicillin resistant Staphylococcus aureus biotypes for association with patient characteristics who had an implant for closed fracture and developed early post-operative wound infections (POWI) in a tertiary care hospital of India.Entities:
Keywords: Epidemiology; MRSA; Orthopedic implants; Post-operative infections
Mesh:
Substances:
Year: 2019 PMID: 30760263 PMCID: PMC6373053 DOI: 10.1186/s12941-019-0307-z
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Molecular typing, virulence, resistance and source data for all MRSA isolates included in the study (N = 50)
| Sequence type (no. of isolates) | CC or singleton | PFGE CLUSTERS | SCC | Biofilm formation | Number of isolates positive for: | Source (s) (no. of isolates) | |||
|---|---|---|---|---|---|---|---|---|---|
| SCC |
|
|
|
| |||||
| ST239 (33) | 239 | D, E, F, H, I and G | III | I | BF (21) | 0 | 0 | Plates and screws (14) | |
| ST22 (9) | 22 | A, B | IV | I | BF (5) | 2 | 9 | Plates and screws (7) | |
| ST30 (2) | 30 | C | IV | III | NBF (2) | 0 | 2 | Hip screw (1), intramedullary nail (1) | |
| ST642 (1) | 30 | C | IV | III | NBF (1) | 0 | 1 | Hip screw (1) | |
| ST772 (2) | 1 | G | V | II | BF (1) | 0 | 2 | Wire (1) | |
| ST1 (1) | 1 | – | V | III | NBF (1) | 1 | 1 | Plate and screw (1) | |
| ST6 (1) | 6 | – | IV | I | BF (1) | 0 | 0 | Plate and screw (1) | |
| ST 107 (1) | – | – | NT | NT | BF (1) | 1 | 0 | Screw (1) | |
ST sequence type, CC clonal complex, S singleton, NT non typeable
Fig. 1Comparative resistance pattern of ST239 against other ST types
PFGE types of MRSA isolates included in the study and their respective antibiotic resistance profiles
| PFGE clusters (no. of isolates) | MRSA isolates | Predominant antibiotic resistance profiles |
|---|---|---|
| A (2) | MRSA 30, 5 | CIP, LVX, ERY, CLI, CXM |
| B (4) | MRSA 21, 47, 48, 40 | CIP, AMC |
| C (3) | MRSA 10, 12, 37 | CIP, SXT, AMC, CXM |
| D (13) | MRSA 19, 2, 20, 4, 34, 42, 43, 44, 14, 31, 33, 35, 36 | ERY, GEN, AMC, CXM |
| E (3) | MRSA 11, 41, 45 | GEN, CXM |
| F (3) | MRSA 49, 7, 8 | ERY, CLI, SXT, GEN, AMC, CXM |
| G (2) | MRSA 27, 28 | CIP, LVX, SXT, AMK, GEN, AMC |
| H (3) | MRSA 17, 9, 3 | CIP, SXT |
| I (2) | MRSA 23, 25 | CIP, LVX, ERY, AMK, GEN, CXM |
Zones of inhibition falling into the category of intermediate susceptibility to a particular antibiotic were considered resistant
Antimicrobial resistance patterns of MRSA from the laboratory. CIP ciprofloxacin, LVX levofloxacin, GEN gentamicin, ERY erythromycin, SXT trimethoprim–sulfamethoxazole, AMK amikacin, DOX doxycycline, CLI clindamycin, AMC amoxyclav, CXM cefuroxime
Association of MRSA isolates with patient characteristics in early SSI of orthopedic implants
| All types of implant infections (N = 50) | ST239 MRSA ( | ST22 MRSA and others ( | Comparison ST239 MRSA vs. ST22 and other ST types |
|---|---|---|---|
| Patient population: female | 11 (36.37%) | 5 (29.4%) | 0.2 |
| Mean age | 40.21 years | 37.35 years | 0.5 |
| Obesity (BMI > 30) | 8 (24.24%) | 4 (23.52%) | 0.9 |
| Mean time between implantation and onset of infection | 14.21 days | 11.29 days | 0.16 |
| Mean duration of antibiotics (antibiotic exposure) | 28.51 days | 19.58 days | 0.000* |
| Elective surgery | 8 (24.24%) | 2 (11.76%) | 0.2 |
| Mean no. of surgical interventions (repeated debridement) | 2.75 | 2.52 | 0.37 |
| Removal of infected implant | 26 (78.79%) | 8 (47.05%) | 0.02* |
| Re-implantation of a new implant | 21 (63.64%) | 6 (35.29%) | 0.05* |
| Cure | 23 (69.69%) | 13 (76.47%) | 0.00* |
| Mean length of hospital stay | 34.9 days | 27.41 days | 0.02* |
*Statistically significant p-values of ≤ 0.05 (two-tailed)